10 April 2017 - Deborah Wilkes
Archived
Stada Arzneimittel is supporting a takeover offer from private-equity firms Bain Capital and Cinven that values the company at EUR5.32 billion (USD5.63 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.